Cas No.: 1926163-30-5
PRODUCT INFORMATION
Description
This tumor-targeted pro-apoptotic peptide, CNGRC-GG-D(KLAKLAK)₂, integrates a tumor-homing CNGRC domain (targeting CD13) and a cytotoxic (KLAKLAK)₂ module. The (KLAKLAK)₂ moiety destabilizes mitochondrial membranes to induce caspase-dependent apoptosis in target cell lines. Its disulfide-bridged architecture enhances accumulation in research models, demonstrating potent in vitro cytotoxic activity.
Molecular Weight
2168.72
Purity
> 95%
Formula
C₉₄H₁₇₄N₃₂O₂₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly-Gly-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys-NH₂ (Disulfide bridge:Cys1-Cys5)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- HN-1 Targeting Peptide (CAT#: OLY-1025-YS-16)
- H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- 3BP-4089 TFA Targeting Peptide (CAT#: OLY-1025-YS-56)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- Rabies Virus Matrix Protein Fragment (RV-MAT) (CAT#: OLY-1025-YS-14)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.